DNMT1 and melanoma: Up to 63% (74 of 117) of the melanoma patients who expired had low ac-DNMT1 protein levels, while 33% (8 of 24) of the alive patients had low ac-DNMT1 protein levels (p = 0.007, χ2 test; Table S2).